常州市存仁生物工程有限公司

Vatalanib Dihydrochloride

Vatalanib Dihydrochloride

Description of:Vatalanib Dihydrochloride
Vatalanib is a potent, selective, orally active inhibitor of the VEGFR tyrosine kinases VEGFR-1 (Flt-1...
更多>>
CP-673451

CP-673451

Description of:CP-673451
 In a sponge angiogenesis model, CP-673451 inhibited 70% of PDGF-BB-stimulated angiogenesis at a dose of 3 mg/kg ...
更多>>
KRN633

KRN633

Description of:KRN633
KRN633 inhibits PDGFR-α and c-Kit at higher concentrations only (IC50 = 0.97 µM and 4.33 µM, respective...
更多>>
Cabozantinib|卡博替尼

Cabozantinib|卡博替尼

Description of:Cabozantinib
Cabozantinib was granted orphan-drug status by the FDA in January 2011.It is currently in a number of clinical tria...
更多>>
Pazopanib(帕唑帕尼)

Pazopanib(帕唑帕尼)

Theoretical analysis:Pazopanib(GW-786034)
M.Wt: 473.98
Formula: C21H23N7O2S.HCL
Solubility: Soluble in DMSO at 10 mmol/L
P...
更多>>
总数: 25 页: 3 / 3 首页 ←上一页 下一页→ 末页

在线联系

点击这里给我发消息